Ulster University Logo

Ulster Institutional Repository

Transvenous cardioversion - A novel asymmetric rectangular biphasic waveform from a radiofrequency defibrillator compared with conventional waveforms in atrial fibrillation

Biomedical Sciences Research Institute Computer Science Research Institute Environmental Sciences Research Institute Nanotechnology & Advanced Materials Research Institute

Walsh, SJ, Manoharan, G, Escalona, OJ, Evans, N, Allen, JD, Anderson, JMCC and Adgey, JAA (2003) Transvenous cardioversion - A novel asymmetric rectangular biphasic waveform from a radiofrequency defibrillator compared with conventional waveforms in atrial fibrillation. JOURNAL OF ELECTROCARDIOLOGY, 36 (Suppl. S). pp. 191-192. [Journal article]

Full text not available from this repository.

DOI: 10.1016/S0022-0736(03)00144-4

Abstract

We investigated a novel device that delivered biphasic and monophasic shocks without tilt, in transvenous cardioversion of atrial fibrillation (AF). The device contains a radiofrequency (RF) transmitting primary, a 15mm air gap and a passive secondary unit that produces the required direct current waveform. Methods: The device was assessed in 10 anaesthetised and ventilated sheep (65 ± SD 12kg). Defibrillation leads were positioned in the distal coronary sinus and the lateral right atrium. The novel RF defibrillator was assessed using rectangular monophasic or biphasic pulses and compared to conventional (C) tilted waveforms (Ventritex HVS-02). During AF placebo shocks were delivered to a 50 Ω dummy load. Sustained AF was induced by rapid atrial pacing and 5 attempts at cardioversion were made for each waveform. Success was defined as reversion to sinus rhythm within 5 beats of shock delivery. Results: No arrhythmic complications were observed for the 400 shocks delivered. Conclusion: A reduction in phase 2 voltage does not affect the efficacy of rectangular waveforms but does facilitate energy reduction. Asymmetric rectangular biphasic waveforms with phase 2 voltage at 50% of phase 1 are more efficacious than equivalent voltage conventional waveforms for transvenous cardioversion of AF. The novel defibrillator is safe and effective. Design modifications will enable this device to be used as an implantable defibrillator with an external RF power source.

Item Type:Journal article
Faculties and Schools:Faculty of Computing & Engineering
Faculty of Computing & Engineering > School of Engineering
Research Institutes and Groups:Engineering Research Institute
Engineering Research Institute > Nanotechnology & Integrated BioEngineering Centre (NIBEC)
ID Code:6082
Deposited By:Professor Omar Escalona
Deposited On:14 Jan 2010 09:16
Last Modified:28 Jun 2011 11:17

Repository Staff Only: item control page